Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GSK plc
Recent news which mentions GSK plc
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
August 01, 2024
Tags
Earnings
Pfizer Inc
Merck & Co Inc
From
CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
Tags
Bristol/Myers Squibb Co
Pharmaceuticals
Health & Science
From
CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
June 17, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Science
From
CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
Tags
Science
Business News
Respiratory syncytial virus
From
CNBC.com News
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
June 03, 2024
Tags
Europe Markets
World Markets
Health care industry
From
CNBC.com News
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
May 31, 2024
Tags
Breaking news
Companies
Moderna Inc
From
CNBC.com News
Moderna says FDA delayed RSV vaccine approval to end of May
May 10, 2024
Tags
Pharmaceuticals
Health & Science
US: News
From
CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
Tags
Politics
Amphastar Pharmaceuticals Inc
AstraZeneca PLC
From
CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
April 09, 2024
Tags
Companies
Breaking news
GSK plc
From
CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
March 26, 2024
Tags
Health care industry
Healthy Returns
AstraZeneca PLC
From
CNBC.com News
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
February 29, 2024
Tags
Business News
Biotechnology
Biotech and Pharmaceuticals
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Europe Markets
Retail industry
ASML Holding NV
From
CNBC.com News
Cramer's Lightning Round: 'Hold off' on Kroger
February 05, 2024
Tags
Bigcommerce Holdings Inc
U/S/ Markets
S&P 500
From
CNBC.com News
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
January 31, 2024
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Johnson & Johnson
United Parcel Service Inc
Merck & Co Inc
From
CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
Tags
Breaking news
Companies
Daiichi Sankyo Co Ltd
From
CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
Tags
US: News
Social issues
Pfizer Inc
From
CNBC.com News
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
October 04, 2023
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Covid, RSV and flu vaccines are now available — here's how to decide whether to get them together
September 15, 2023
Tags
Pharmaceuticals
Health & Science
Pfizer Inc
From
CNBC.com News
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
September 13, 2023
Tags
Immunizations
Biotechnology
Biotech and Pharmaceuticals
From
CNBC.com News
Covid vaccine rollout begins early in the UK with new variant under watch
September 11, 2023
Tags
Europe News
Europe Markets
Health care industry
From
CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
August 10, 2023
Tags
Business
GSK plc
Health care industry
From
CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
August 02, 2023
Tags
US: News
Walgreens Boots Alliance Inc
Pfizer Inc
From
CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
Tags
US: News
Pharmaceuticals
Health & Science
From
CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
June 29, 2023
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Stocks making the biggest moves midday: Starbucks, CarMax, Virgin Galactic and more
June 23, 2023
Tags
Virgin Galactic Holdings Inc
Economy
Breaking News: Markets
From
CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
Tags
Pfizer Inc
Social issues
US: News
From
CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
June 21, 2023
Tags
Immunizations
Biotechnology
Vaccinations
From
CNBC.com News
Stocks making the biggest moves midday: Dollar Tree, Amazon, FedEx and more
June 21, 2023
Tags
Uniqure NV
Palantir Technologies Inc
GSK plc
From
CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
June 21, 2023
Tags
Breaking news
Companies
Health care industry
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.